April 1, 1998International Journal of Gynecology & Obstetrics

Antiphospholipid antibodies and lipoprotein (a) in women with recurrent fetal loss

View Full Paper

Ask AI

Bookmark

Why the study?

Are lupus anticoagulant, anticardiolipins, and lipoprotein (a) associated with recurrent fetal loss in women?

Population

93 women, comprising 43 with recurrent fetal loss and 50 controls.

Design

Cohort

Authors

MSMaciej SzczepańskiAnimal and Plant Health Inspection Service ABAlicja BauerPostgraduate School of Molecular Medicine AGA GardasTulane University

Discussion

Member takes

Implication

Elevated Lp(a) was associated with recurrent fetal loss; leaves open prognostic value and requires prospective validation.

Structured PICO

Are lupus anticoagulant, anticardiolipins, and lipoprotein (a) associated with recurrent fetal loss in women?

Population

93 women, comprising 43 with recurrent fetal loss (≥2 losses; 32 nullipara, 11 parous) and 50 controls (35 never pregnant, 15 parous without miscarriage).

Comparator

Control groups of women who were never pregnant (n=35) and parous women without any miscarriage (n=15).

Outcome

Occurrence of lupus anticoagulant, IgG and IgM anticardiolipins, and lipoprotein (a).surrogate

Elevated lipoprotein (a) may have prognostic significance in women predisposed to recurrent fetal loss, whereas lupus anticoagulant and anticardiolipin antibodies showed less clear associations in this cohort.

Cite This Study

Szczepański et al. (1998) studied this question.

synapsesocial.com/papers/6a8a5458e0083a7c2c436a54 https://doi.org/10.1016/s0020-7292(98)00007-1

View Full Paper

Ask AI

Bookmark

Antiphospholipid antibodies and lipoprotein (a) in women with recurrent fetal loss

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Antiphospholipid antibodies and lipoprotein (a) in women with recurrent fetal loss

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider